RICCARDI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 6.101
AS - Asia 4.738
EU - Europa 3.991
SA - Sud America 466
AF - Africa 113
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.442
Nazione #
US - Stati Uniti d'America 5.996
CN - Cina 2.567
SG - Singapore 1.086
UA - Ucraina 806
IE - Irlanda 753
FI - Finlandia 482
DE - Germania 470
HK - Hong Kong 434
SE - Svezia 363
BR - Brasile 353
RU - Federazione Russa 294
VN - Vietnam 258
FR - Francia 241
IT - Italia 229
GB - Regno Unito 219
IN - India 89
CA - Canada 65
AR - Argentina 46
ZA - Sudafrica 45
BD - Bangladesh 42
IQ - Iraq 30
TR - Turchia 28
JP - Giappone 27
AU - Australia 24
MX - Messico 23
BE - Belgio 21
PL - Polonia 20
MY - Malesia 19
ID - Indonesia 18
VE - Venezuela 18
CZ - Repubblica Ceca 17
PK - Pakistan 17
KR - Corea 16
NL - Olanda 13
CO - Colombia 12
EG - Egitto 12
UZ - Uzbekistan 12
CL - Cile 11
JO - Giordania 11
MA - Marocco 11
EC - Ecuador 10
PH - Filippine 10
SA - Arabia Saudita 10
DZ - Algeria 8
ES - Italia 8
GR - Grecia 8
IR - Iran 8
NZ - Nuova Zelanda 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
TH - Thailandia 7
ET - Etiopia 6
AL - Albania 5
DO - Repubblica Dominicana 5
IL - Israele 5
PE - Perù 5
TW - Taiwan 5
CH - Svizzera 4
DK - Danimarca 4
NP - Nepal 4
PT - Portogallo 4
PY - Paraguay 4
RS - Serbia 4
AT - Austria 3
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LT - Lituania 3
OM - Oman 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
HN - Honduras 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
ML - Mali 2
MU - Mauritius 2
NG - Nigeria 2
PA - Panama 2
TG - Togo 2
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BW - Botswana 1
CI - Costa d'Avorio 1
CM - Camerun 1
EE - Estonia 1
GE - Georgia 1
IM - Isola di Man 1
LC - Santa Lucia 1
LV - Lettonia 1
Totale 15.426
Città #
Chandler 889
Jacksonville 861
Dublin 752
San Jose 726
Nanjing 615
Singapore 587
Ashburn 448
Hong Kong 418
Beijing 328
Boardman 286
Dallas 260
Nanchang 246
Princeton 197
Lawrence 174
Changsha 173
Shenyang 171
Hebei 158
Lauterbourg 155
Wilmington 136
Helsinki 135
Los Angeles 128
Medford 127
Jiaxing 111
Tianjin 109
Ho Chi Minh City 100
Hangzhou 96
Milan 80
Ann Arbor 74
Buffalo 68
Redondo Beach 62
Hanoi 56
Council Bluffs 54
New York 51
Munich 47
Houston 44
Verona 44
Moscow 41
Shanghai 40
Woodbridge 37
Johannesburg 32
Toronto 31
Norwalk 30
Orem 29
Kunming 28
São Paulo 28
Chicago 25
San Francisco 24
Seattle 23
Guangzhou 22
Brussels 20
Tokyo 20
Brooklyn 19
Jinan 19
Santa Clara 19
Warsaw 18
Frankfurt am Main 17
Atlanta 16
Chennai 16
Montreal 15
Zhengzhou 15
Boston 14
Falkenstein 14
Rio de Janeiro 14
Da Nang 13
Pavia 13
Baghdad 12
Des Moines 12
Turku 12
Auburn Hills 11
Belo Horizonte 11
Fairfield 11
Mexico City 11
Mumbai 11
San Genesio Ed Uniti 11
Stockholm 11
Melbourne 10
Dhaka 9
Manchester 9
Tashkent 9
Amman 8
Brno 8
Campinas 8
Denver 8
Falls Church 8
George Town 8
Haiphong 8
New Delhi 8
Ningbo 8
Nuremberg 8
Prague 8
Athens 7
Brasília 7
Can Tho 7
Haikou 7
Lanzhou 7
London 7
Secaucus 7
Sydney 7
Addis Ababa 6
Barquisimeto 6
Totale 9.924
Nome #
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. 259
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 152
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 135
Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients 127
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study 127
Use of bisphosphonates in oncology: physiopathologic bases and clinical activity. 126
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 126
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. 126
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01). 123
Cell kinetic characterization of human brain tumors 123
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 120
A study of biological behaviour of human brain tumors. Part I. Arachidonic acid metabolism and DNA content. 119
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 117
Anemie in oncologia. 116
A prospective comparison of a-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients 115
In vitro killing of colorectal carcinoma cells by autologous activated NK cells is boosted by anti-epidermal growth factor receptor-induced ADCC regardless of RAS mutation status 115
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 114
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 114
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. 114
- GM-CSF increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications and bone marrow kinetics. 113
AIDS-associated non-Hodgkin's lymphomas in Italy: intravenous drug abusers versus homosexual men 113
A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. 113
A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera. 110
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. 110
- Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational controlled trial. 109
G2 synchronization in human acute leukemia after VP 16 213 therapy. 109
VEGF-induced intracellular Ca2+oscillations are down-regulated and do not stimulate angiogenesis in breast cancer-derived endothelial colony forming cells 109
Linee guida per la diagnosi, il trattamento e la riabilitazione del carcinoma polmonare 107
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 107
Biological effects of pegfilgrastim on circulating neutrophils in breast cancer patients undergoing dose-dense chemotherapy. 107
Anemie megaloblastiche. 107
Strategies of medical treatment for metastatic breast cancer 105
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues. 105
Anemie megaloblastiche. 105
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 104
A rapid cytofluorometric method for quantitative DNA determination on fixed smears. 103
Effect of recombinant gamma interferon on the proliferative activity of cultured leukemic cells. 103
Breast and renal cancer—Derived endothelial colony forming cells share a common gene signature 103
The PAS reactivity of lymph-node blast cells in non-Hodgkin's malignant lymphomas. 101
Changing clinical presentation of multiple myeloma. 100
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. V. Effect of VP 16 213 studied with flow cytofluorometry and cytoautoradiography. 99
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult. 99
New agents in medical oncology and the risk of venous thromboembolism. 99
Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. 99
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 98
P-glycoprotein expression in multiple myeloma. 98
Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. 98
Double heterozygosity for haemoglobin Malmø [ß97 (FG4) His-Glu] and ß-thalassemia traits, with unusually high haematocrit values, in a Sicilian man. 97
Cytokinetic studies in two cases of plasma cell leukemia. 96
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomized study by the Italian Trials in Medical Oncology (ITMO) Group. 96
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 95
Cell kinetics of CD34-positive hematopoietic cells following chemotherapy plus colony-stimulating factors in advanced breast cancer. 95
Biologia e clinica del mieloma multiplo. 95
Ploidy and proliferative activity in uterine tumors: an in vivo study using bromodeoxyuridine and flow cytometry. 94
Intrathecal methotrexate neurotoxicity. 94
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study. 94
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomised protocol. 94
Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients 94
DNA content analysis of peripheral blood B-lymphocytes in plasma cell malignancies 93
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 93
I linfomi non Hodgkin (linfosarcomi, reticolosarcomi). 93
Preoperative Carbon Ion Radiotherapy (CIRT) with Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma (PCa): A Multicenter Prospective Phase II Clinical Study (Pioppo Study NCT 03822936) 92
Sequential intrahepatic and systemic fluoropyrimidines-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study. 92
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 92
Central indwelling catheter to prevent phlebosclerosis by Peptichemio in patients with multiple myeloma 92
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 91
Doubling the epirubicin dosage in the 5-fluorouracil, epirubicin and cyclophosphamide (FEC) regimen for advanced breast cancer: a prospective, randomized, multicentric study on antitumor effect and life quality 91
Il trattamento medico del carcinoma mammario. 91
Fisiopatologia dell'eritrocito. 91
Weekly taxanes in metastatic breast cancer. 90
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. 90
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 90
Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation. 89
Studio morfologico e citochimico dei megacariociti in 25 casi di displasie emopoietiche. 89
Myelodysplastic syndromes: biologic and clinical aspects. 89
Cell kinetic studies of human intracranial tumors. 89
Acute rhabdomyolysis after high dose chemotherapy and circulating progenitor cell autografting for breast cancer. 89
Interim analysis of the Grocta 8 adjuvant trial in breast cancer patients with ten or more involved nodes 88
Gemcitabine and oxaliplatin to treat immunotherapy-resistant advanced renal cell carcinoma patients: final results of a single institution phase II study 88
Deoxyribonucleic acid content of cleaved and non-cleaved cells in follicular center cell lymphomas. 88
Prerequisites for in vivo cell kinetic studies in patients. 87
Expression of p53 protein during the cell cycle mesaured by flow cytometry in human leukemia. 87
Interferon alpha-2b in the long-term treatment of essential thrombocythemia. 87
Fisiopatologia dell'eritrocito. 87
High-dose chemotherapy (HDT) with tandem autologous peripheral blood cells (PBPC) transplantation for patients with metastatic breast cancer (MBC) 87
Angiogenesi: esperienze cliniche 86
The use of peripheral blood haemopoietic progenitors mobilized with standard dose chemotherapy plus G-CSF to support multicyclic dose-intensive chemotherapy for advanced breast cancer. 86
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for Unresectable Hepatic Tumors. 86
Myeloprotective effect of early primary granulocyte-colony stimulating factor during intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. 85
Effect of Vincristine on the bone marrow cells of patients with multiple myeloma: a cytomorphologic study. 85
Applicazioni cliniche dei fattori di crescita emopoietici. 85
Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non lymphoblastic leukemia. 85
La citofluorimetria a flusso nella diagnostica ematologica ed oncologica. 85
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 84
Simultaneous detection of cellular p21 ras oncogene product and DNA content by two parameter flow cytometry 84
Serum Pharmacokinetics in Patients Treated with Transarterial Chemoembolization (TACE) Using Two Types of Epirubicin-loaded Microspheres. 84
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 83
Flow cytometric DNA index in the prognosis of colorectal cancer. 83
HER-2 / neu oncogene expression and DNA ploidy in normal human kidney and renal cell carcinoma. 83
Expression of p170 multidrug resistance protein in multiple myeloma: a clinical study. 83
Totale 10.137
Categoria #
all - tutte 61.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 0 0 0 0 0 55
2021/2022810 5 2 21 11 20 32 19 31 41 16 127 485
2022/20232.425 301 127 25 238 317 257 0 134 914 14 53 45
2023/2024718 130 146 25 62 68 167 11 28 8 29 27 17
2024/20251.921 42 208 54 73 41 53 66 181 434 42 192 535
2025/20264.523 351 367 438 434 444 280 1.003 175 397 368 199 67
Totale 15.503